RDY 18 Pill - purple capsule/oblong, 12mm
Pill with imprint RDY 18 is Purple, Capsule/Oblong and has been identified as Methylphenidate Hydrochloride Extended-Release 18 mg. It is supplied by Dr. Reddy's Laboratories, Inc.
Methylphenidate is used in the treatment of ADHD; Narcolepsy; Depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 18 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for RDY 18
Methylphenidate Hydrochloride Extended-Release
- Imprint
- RDY 18
- Strength
- 18 mg
- Color
- Purple
- Size
- 12.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Dr. Reddy's Laboratories, Inc.
- National Drug Code (NDC)
- 43598-0438
Related images for "RDY 18"
More about methylphenidate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,091)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
Patient resources
- Methylphenidate drug information
- Methylphenidate transdermal
- Methylphenidate Chewable Tablets
- Methylphenidate Controlled-Release Tablets
- Methylphenidate Extended-Release Chewable Tablets
Other brands
Concerta, Ritalin, Jornay PM, Ritalin LA, ... +10 more
Professional resources
- Methylphenidate monograph
- Methylin Chewable Tablet (FDA)
- Methylphenidate CD Capsules (FDA)
- Methylphenidate Chewable Tablets (FDA)
- Methylphenidate ER Capsules (FDA)
Other brands
Concerta, Ritalin, Jornay PM, Ritalin LA, ... +10 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.